Nexien BioPharma (NXEN) Stock Price, News & Analysis

Company Overview

Nexien BioPharma, Inc. focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado.

Key Stats

• Today's Range: $0.0056 to $0.0056
• 50-Day Range: $0.01 to $0.05
• 52-Week Range: $0.00 to $0.05
• Volume: N/A
• Average Volume: 16,660 shs
• Market Capitalization: $396,323.20
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

NXEN Stock Analysis - Frequently Asked Questions

How have NXEN shares performed this year?

Nexien BioPharma's stock was trading at $0.0259 at the beginning of 2024. Since then, NXEN stock has decreased by 78.4% and is now trading at $0.0056.
View the best growth stocks for 2024 here.

How do I buy shares of Nexien BioPharma?

Shares of NXEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Nexien BioPharma own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Nexien BioPharma investors own include Labor Smart (LTNC), Acrivon Therapeutics (ACRV), Processa Pharmaceuticals (PCSA), Aurora Innovation (AUR), NVIDIA (NVDA), American Cannabis (AMMJ) and American Noble Gas (AMNI).

Company Calendar

• Today: 12/22/2024
• Fiscal Year End: 6/30/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:NXEN
• CUSIP: N/A
• CIK: 1625288
• Web: www.nexienbiopharma.com
• Phone: (303) 495-7583
• Fax: N/A
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-240,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -3,028.21%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.01
• Quick Ratio: 0.01

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.01) per share
• Price / Book: -0.56

Miscellaneous

• Outstanding Shares: 70,772,000
• Free Float: 49,116,000
• Market Cap: $396,323.20
• Optionable: Not Optionable
• Beta: 0.58